The influence of CCPA and RF on the five-year outcomes in patients with early rheumatoid arthritisиве

Bibliography:
1. Karateev DE. A current view on the problem of rapidly progressive rheumatoid arthritis. Modern Rheumatology Journal 2010; (2): 36-40
2. Landewe R. Predictive markers in rapidly progressing rheumatoid arthritis. J Rheumatol. 2007; 80: 8-15
3. Karateev DE. Basic trends and variability of rheumatoid arthritis evolution: long-term follow-up results. Rheumatology Science and Practice 2010; (2): 36-40
4. Combe В, Dougados М, Goupille Р, et al. Prognostic Factors for Radiographic Damage in Early Rheumatoid Arthritis/ Arthritis & Rheumatism 2001; 8 (44): 1736-43
5. Paimela L, Palosuo T, Helve T, Ano K. Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis. Br.J. Rheumat. 1995; 34: 1146-50
6. Forslind K, Ahilmen M, Eberhardt K, et al. Prediction of radiological outcome in early RA in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004; 63: 1090-95
7. Machold KP, Stamm ТА, Nell VPK, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology 2007; 46: 342-49
8. Courvoisier N, Dougados M, Cantagrel A, et al. Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study. Arthritis Research & Therapy 2008; 10: R10.